- Home
- MNRO vs BME Comparison
MNRO vs BME Comparison
Compare MNRO & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MNRO | BME |
|---|---|---|
| Founded | 1957 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Automotive Aftermarket | Trusts Except Educational Religious and Charitable |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 472.5M | 511.9M |
| IPO Year | 1994 | 2005 |
Fundamental Metrics
Financial Performance| Metric | MNRO | BME |
|---|---|---|
| Price | $15.82 | $39.16 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $16.00 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 49.3K |
| Earning Date | 05-27-2026 | 01-01-0001 |
| Dividend Yield | ★ 6.69% | N/A |
| EPS Growth | ★ 113.64 | N/A |
| EPS | ★ 0.03 | N/A |
| Revenue | ★ $1,157,176,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.59 | N/A |
| P/E Ratio | $525.67 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $13.51 | $35.03 |
| 52 Week High | $23.91 | $42.74 |
Technical Indicators
Market Signals| Indicator | MNRO | BME |
|---|---|---|
| Relative Strength Index (RSI) | 43.32 | 46.57 |
| Support Level | $14.90 | $38.03 |
| Resistance Level | $18.24 | $39.69 |
| Average True Range (ATR) | 0.99 | 0.53 |
| MACD | -0.03 | 0.06 |
| Stochastic Oscillator | 20.60 | 36.95 |
Price Performance
Historical ComparisonAbout MNRO Monro Inc.
Monro Inc is an operator of retail tire and automotive repair stores in the United States. The company offers replacement tires and tire related services, automotive undercar repair services, and a broad range of routine maintenance services, on passenger cars, light trucks, and vans. It also provides other products and services for brakes; mufflers and exhaust systems; and steering, drive train, suspension, and wheel alignment.
About BME Blackrock Health Sciences Trust
Blackrock Health Sciences Trust has an investment objective to provide total return and income mainly through long-term capital appreciation. The Trust invests the majority of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry.